Belvedere Trading
VYGR icon

Belvedere Trading’s Voyager Therapeutics VYGR Stock Holding History

Belvedere Trading’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,432
Closed -$182K – 424
2022
Q2 		$182K Sell
26,432
-9,908
-27% -$66.9K 0.01% 191
2022
Q1 		$347K Buy
36,340
+1,683
+5% +$7.51K 0.01% 149
2021
Q4 		$98K Sell
34,657
-28,034
-45% -$95.7K ﹤0.01% 309
2021
Q3 		$285K Buy
+62,691
New +$204K 0.01% 194

Other funds holding VYGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Belvedere Trading's VYGR Position: Q3 2022 in Review

Belvedere Trading sold out of Voyager Therapeutics (VYGR) in Q3 2022, closing a stake of 26,432 shares — an estimated $182K sold.

Belvedere Trading first reported a position in VYGR in Q3 2021 and held it in 4 quarters. The position peaked at $347K in Q1 2022. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2022.

  • Belvedere Trading reported no remaining Voyager Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Belvedere Trading sold 26,432 Voyager Therapeutics shares in Q3 2022, an estimated $182K.
  • Belvedere Trading first reported a position in Voyager Therapeutics in Q3 2021 and held it in 4 quarters.
  • Belvedere Trading's Voyager Therapeutics position peaked at $347K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2022.

Based on Belvedere Trading's 13F filing for Q3 2022, filed 26 Oct 2022.